lncRNA H19 promotes glioblastoma multiforme development by activating autophagy by sponging miR-491-5p

References

• Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492–507.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.
   PubMed Web of Science ®Google Scholar
• Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. Jama. 2013;310:1842–1850.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Xu J, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro Oncol. 2016;18:v1–v75.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27–42.
   PubMed Web of Science ®Google Scholar
• White E. The role for autophagy in cancer. J Clin Invest. 2015;125:42–46.
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112:1809–1820.
   PubMed Web of Science ®Google Scholar
• Mathew R, Khor S, Hackett SR, et al. Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity. Mol Cell. 2014;55:916–930.
   PubMed Web of Science ®Google Scholar
• Singh SS, Vats S, Chia AY, et al. Dual role of autophagy in hallmarks of cancer. Oncogene. 2018;37:1142–1158.
   PubMed Web of Science ®Google Scholar
• Taylor MA, Das BC, Ray SK. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma. Apoptosis. 2018;23:563–575.
   PubMed Web of Science ®Google Scholar
• Novikova IV, Hennelly SP, Sanbonmatsu KY, et al. Sizing up long non-coding RNAs: do lncRNAs have secondary and tertiary structure? Bioarchitecture. 2012;2:189–199.
   PubMedGoogle Scholar
• Zhang X, Wang W, Zhu W, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci. 2019;20 :5573.
   PubMed Web of Science ®Google Scholar
• DeSouza PA, Qu X, Chen H, et al. Noncoding RNA dysregulation in glioblastoma. Cancers (Basel). 2021;14:13.
   PubMed Web of Science ®Google Scholar
• Stackhouse CT, Gillespie GY, Willey CD. Exploring the roles of lncRNAs in GBM pathophysiology and their therapeutic potential. Cells. 2020;9:2369.
   PubMed Web of Science ®Google Scholar
• Tao C, Luo H, Chen L, et al. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in glioma. Bioengineered. 2021;12:4016–4031.
   PubMed Web of Science ®Google Scholar
• Collette J, Le Bourhis X, Adriaenssens E. Regulation of human breast cancer by the long non-coding RNA H19. Int J Mol Sci. 2017;18 :2319.
   PubMed Web of Science ®Google Scholar
• Flouzat-Lachaniette CH, Jullien N, Bouthors C, et al. A novel in vivo porcine model of intervertebral disc degeneration induced by cryoinjury. Int Orthop. 2018;42:2263–2272.
   PubMed Web of Science ®Google Scholar
• Yoshimura H, Matsuda Y, Yamamoto M, et al. Reduced expression of the H19 long non-coding RNA inhibits pancreatic cancer metastasis. Lab Invest. 2018;98:814–824.
   PubMed Web of Science ®Google Scholar
• Fawzy MS, Ellawindy A, Hussein MH, et al. Long noncoding RNA H19, and not microRNA miR-326, is over-expressed and predicts survival in glioblastoma. Biochem Cell Biol. 2018;96:832–839.
   PubMed Web of Science ®Google Scholar
• Jiang X, Yan Y, Hu M, et al. Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. J Neurosurg. 2016;2016:129–136.
   PubMed Web of Science ®Google Scholar
• Wu W, Hu Q, Nie E, et al. Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma. Sci Rep. 2017;7:45029.
   PubMed Web of Science ®Google Scholar
• Yu T, Wang LN, Li W, et al. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4. Cancer Sci. 2018;109:1393–1403.
   PubMed Web of Science ®Google Scholar
• Sun R, Liu Z, Tong D, et al. miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer. Cell Death Dis. 2017;8:e2714.
   PubMed Web of Science ®Google Scholar
• Denoyelle C, Lambert B, Meryet-Figuière M, et al. miR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activation. Cell Death Dis. 2014;5:e1445.
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology. 2011;54:1679–1689.
   PubMed Web of Science ®Google Scholar
• Wang SH, Ma F, Tang ZH, et al. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer. J Exp Clin Cancer Res. 2016;35:160.
   PubMed Web of Science ®Google Scholar
• Hardee ME, Marciscano AE, Medina-Ramirez CM, et al. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β. Cancer Res. 2012;72:4119–4129.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li C, Shang L, et al. Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells. Springerplus. 2016;5:235.
   PubMedGoogle Scholar
• Sesen J, Dahan P, Scotland SJ, et al. Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. PLOS ONE. 2015;10:e0123721.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zou YG, Xue YZ, et al. Long non-coding RNA H19 protects acute myocardial infarction through activating autophagy in mice. Eur Rev Med Pharmacol Sci. 2018;22:5647–5651.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu Z, Li Y, et al. Long non-coding RNA H19 promotes proliferation, migration and invasion and inhibits apoptosis of breast cancer cells by targeting miR-491-5p/ZNF703 axis. Cancer Manag Res. 2020;12:9247–9258.
   PubMed Web of Science ®Google Scholar
• Li X, Liu Y, Granberg KJ, et al. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene. 2015;34:1619–1628.
   PubMed Web of Science ®Google Scholar
• Møller HG, Rasmussen AP, Andersen HH, et al. A systematic review of MicroRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol. 2013;47:131–144.
   PubMed Web of Science ®Google Scholar
• Jiang MC, Ni JJ, Cui WY, et al. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9:1354–1366.
   PubMed Web of Science ®Google Scholar
• Alipoor B, Parvar SN, Sabati Z, et al. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance. Mol Biol Rep. 2020;47:6357–6374.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhong J, Chen F, et al. Association between lncRNA H19 rs217727 polymorphism and the risk of cancer: an updated meta-analysis. BMC Medical Genetics. 2019;20:186.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhao Y, Li Y, et al. Quantitative assessment of lncRNA H19 polymorphisms and cancer risk: a meta-analysis based on 48,166 subjects. Artif Cells Nanomed Biotechnol. 2020;48:15–27.
   PubMed Web of Science ®Google Scholar
• Li X, Yang H, Wang J, et al. High level of lncRNA H19 expression is associated with shorter survival in esophageal squamous cell cancer patients. Pathol Res Pract. 2019;215:152638.
   PubMed Web of Science ®Google Scholar
• Özgür E, Ferhatoğlu F, Şen F, et al. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer. Cancer Biomarkers. 2020;27:11–17.
   PubMed Web of Science ®Google Scholar
• Zhang T, Lei F, Jiang T, et al. H19/miR-675-5p targeting SFN enhances the invasion and metastasis of nasalpharyngeal cancer cells. Curr Mol Pharmacol. 2019;12:324–333.
   PubMed Web of Science ®Google Scholar
• Wang D, Xing N, Yang T, et al. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis. Cancer Med. 2020;9:7218–7230.
   PubMed Web of Science ®Google Scholar
• Peperstraete E, Lecerf C, Collette J, et al. Enhancement of breast cancer cell aggressiveness by lncRNA H19 and its Mir-675 derivative: insight into shared and different actions. Cancers (Basel). 2020;12:1730.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhu Z, Li J, et al. Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses. Aging (Albany NY). 2020;12:3407–3430.
   PubMedGoogle Scholar
• Li W, Jiang P, Sun X, et al. Suppressing H19 modulates tumorigenicity and stemness in U251 and U87MG glioma cells. Cell Mol Neurobiol. 2016;36:1219–1227.
   PubMed Web of Science ®Google Scholar
• Fazi B, Garbo S, Toschi N, et al. The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter. Oncotarget. 2018;9:15512–15525.
   PubMedGoogle Scholar
• Yun CW, Lee SH. The roles of autophagy in cancer. Int J Mol Sci. 2018;19:3466.
   PubMed Web of Science ®Google Scholar
• Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93:266–276.
   PubMed Web of Science ®Google Scholar
• Ma X, Li Y, Zhao B. Ribosomal protein L5 (RPL5)/ E2F transcription factor 1 (E2F1) signaling suppresses breast cancer progression via regulating endoplasmic reticulum stress and autophagy. Bioengineered. 2022;13:8076–8086.
   PubMed Web of Science ®Google Scholar
• Fancello L, Kampen KR, Hofman IJ, et al. The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types. Oncotarget. 2017;8:14462–14478.
   PubMedGoogle Scholar
• Xu Y, Li R, Li X, et al. An Autophagy-related gene signature associated with clinical prognosis and immune microenvironment in gliomas. Front Oncol. 2020;10:571189.
   PubMed Web of Science ®Google Scholar
• Lee IH, Cao L, Mostoslavsky R, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci U S A. 2008;105:3374–3379.
   PubMed Web of Science ®Google Scholar
• Panda PK, Fahrner A, Vats S, et al. Chemical screening approaches enabling drug discovery of autophagy modulators for biomedical applications in human diseases. Front Cell Dev Biol. 2019;7:38.
   PubMed Web of Science ®Google Scholar
• Mareninova OA, Jia W, Gretler SR, et al. Transgenic expression of GFP-LC3 perturbs autophagy in exocrine pancreas and acute pancreatitis responses in mice. Autophagy. 2020;16:2084–2097.
   PubMed Web of Science ®Google Scholar
• Tanida I, Minematsu-Ikeguchi N, Ueno T, et al. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1:84–91.
   PubMed Web of Science ®Google Scholar
• Ni HM, Bockus A, Wozniak AL, et al. Dissecting the dynamic turnover of GFP-LC3 in the autolysosome. Autophagy. 2011;7:188–204.
   PubMed Web of Science ®Google Scholar
• Kim S, Choi S, Kang D. Quantitative and qualitative analysis of autophagy flux using imaging. BMB Rep. 2020;53:241–247.
   PubMed Web of Science ®Google Scholar
• Zhuo C, Jiang R, Lin X, et al. LncRNA H19 inhibits autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy. Oncotarget. 2017;8:1429–1437.
   PubMedGoogle Scholar
• Wang J, Xie S, Yang J, et al. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy. J Hematol Oncol. 2019;12:81.
   PubMed Web of Science ®Google Scholar
• Wang M, Han D, Yuan Z, et al. Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy. Cell Death Dis. 2018;9:1149.
   PubMed Web of Science ®Google Scholar
• Yan W, Zhang W, Sun L, et al. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme. Brain Res. 2011;1411:108–115.
   PubMed Web of Science ®Google Scholar
• Meng Y, Shang FR, Zhu YL. MiR-491 functions as a tumor suppressor through Wnt3a/β-catenin signaling in the development of glioma. Eur Rev Med Pharmacol Sci. 2019;23:10899–10907.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xu W, Ni P, et al. MiR-99a and MiR-491 regulate cisplatin resistance in human gastric cancer cells by targeting CAPNS1. Int J Biol Sci. 2016;12:1437–1447.
   PubMed Web of Science ®Google Scholar
• Lu L, Cai M, Peng M, et al. miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer. Cancer Manag Res. 2019;11:1805–1816.
   PubMed Web of Science ®Google Scholar
• Guo J, Luo C, Yang Y, et al. MiR-491-5p, as a tumor suppressor, prevents migration and invasion of breast cancer by targeting ZNF-703 to regulate AKT/mTOR pathway. Cancer Manag Res. 2021;13:403–413.
   PubMed Web of Science ®Google Scholar
• Basso J, Paggi MG, Fortuna A, et al. Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma. Mol Genet Genomics. 2022;297:507–521.
   PubMed Web of Science ®Google Scholar
• Chaurasia M, Gupta S, Das A, et al. Radiation induces EIF2AK3/PERK and ERN1/IRE1 mediated pro-survival autophagy. Autophagy. 2019;15:1391–1406.
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang B, Wang Z, et al. COPS5 negatively regulates goat endometrial function via the ERN1 and mTOR-autophagy pathways during early pregnancy. J Cell Physiol. 2019;234:18666–18678.
   PubMed Web of Science ®Google Scholar
• Kim TW, Lee SY, Kim M, et al. Kaempferol induces autophagic cell death via IRE1-JNK-CHOP pathway and inhibition of G9a in gastric cancer cells. Cell Death Dis. 2018;9:875.
   PubMed Web of Science ®Google Scholar